Pharmacophoric features of biguanide derivatives: An electronic and structural analysis

Journal of Medicinal Chemistry

Volumn 48, Issue 24, 2005, Pages 7615-7622

  Bharatam, Prasad V ^a   Patel, Dhilon S ^a   Iqbal, Pansy ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; PROGUANIL;

AB INITIO CALCULATION; ARTICLE; DENSITY FUNCTIONAL THEORY; DRUG CONFORMATION; DRUG MECHANISM; DRUG STABILITY; ELECTRICITY; ELECTRON TRANSPORT; ELECTRONICS; MOLECULAR ELECTROSTATIC POTENTIAL; PHARMACOPHORE; PROTON TRANSPORT; STRUCTURE ANALYSIS;

BIGUANIDES; ELECTROSTATICS; ISOMERISM; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTONS; THERMODYNAMICS;

EID: 28144436555     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050602z     Document Type: Article

References (59)

1. Campbell, R. K.; White, J. R.; Saulie, B. A. Metformin: A New Oral Biguanide. Clin. Ther. 1996, 18, 360-371.
2. Uchiyama, H.; Okamoto, A.; Sato, K.; Yamada, T.; Murakami, S.; Yoneda, S.; Kajita, Y.; Tegoshi, T.; Arrirono, N. Quinine-Resistant Severe Falciparum Malaria Effectively Treated with Atovaquone and Proguanil Hydrochloride Combination Therapy. Intern. Med. (Tokyo, Jpn) 2004, 43, 624-627.
3. Davidoff, F.; Carr, S. Calcium-like Action of Phenethylbiguanide and Related Compounds: Inhibition of Pyruvate Kinase. Proc. Natl. Acad. Sci. U.S.A. 1972, 69, 1957-1961.
4. Ohara, S.; Komatsu, R.; Matsuyama, T. Short-term Effect of Buformin, a Biguanide, on Insulin Sensitivity, Soluble Fraction of Tumor Necrosis Factor Receptor and Serum Lipids in Overweight Patient with Type 2 Diabetes Mellitus. Diabetes Res. Clin. Pract. 2004, 66, 133-138.
5. Rahman, A. A.; Daoud, M. K.; Dukat, M.; Herrick-Davis, K.; Purohit, A.; Teitler, M.; Amaral, A. T.; Malvezzi, A.; Glennon, R. A. Conformationally- Restricted Analogues and Partition Coefficients of the 5-HT3 Serotonin Receptor Ligands meta-Chlorophenylbiguanide (mCPBG) and meta-Chlorophenylguanidine (mCPG). Bioorg. Med. Chem. 2003, 13, 1119-1123.
6. Thomas, L.; Russell, A. D.; Maillard, J. Y. Antimicrobial Activity of Chlorhexidine Diacetate and Benzalkonium Chloride Against Pseudomonas aeruginosa and its Response to Biocide Residues. J. Appl. Microbiol. 2005, 98, 533-543.
7. Denys, A.; Machlanski, T.; Bialek, J.; Mrozicki, S. Relation Between Chemical Structure and Antiviral Activity of Some Biguanide Derivatives. Praeventivmedizin 1977, 164, 85-89.
8. Tanzer, J. M.; Slee, A. M.; Kamay, B. A. Structural Requirements of Guanide, Biguanide, and Bisbiguanide Agents for Antiplaque Activity. Antimicrob. Agents Chemother. 1977, 12, 721-729.
9. Pinelli, A.; Trivulzio, S.; Pojaga, G.; Rossoni, G. Effects of 2-guanidine-4-methylquinazoline on Gastric Acid Secretion in Rats. Pharmacol. Res. 1996, 34, 225-230.
10. Pinelli, A.; Colombo, R.; Trivulzio, S.; Berti, F.; Tofanetti, O.; Caimi, B. R. Inhibitory Effects of 2-Guanidinebenzimidazole and 1-Phenylbiguanide on Gastric Acid Secretion in Rats. Arzneim.-Forsch. 1984, 34, 890-894.
11. Holland, W.; Morrison, T.; Chang, Y.; Wiernsperger, N.; Stith, B. J. Metformin (Glucophage) Inhibits Tyrosine Phosphatase Activity to Stimulate the Insulin Receptor Tyrosine Kinase. Biochem. Pharmacol. 2004, 67, 2081-2091.
12. Zou, M. H.; Kirkpatrick, S. S.; Davis, B. J.; Nelson, J. S.; Wiles, W. G.; Schlattner, U.; Neumann, D.; Brownlee, M.; Freeman, M. B.; Goldman, M. H. Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in vivo. J. Biol. Chem. 2004, 279, 43940-43951.
13. Zhou, G.; Myers, R.; Li, Y.; Chen, Y.; Shen, X.; Fenyk-Melody, J.; Wu, M.; Ventre, J.; Doebber, T.; Fujii, N.; Musi, N.; Hirshman, M. F.; Goodyear, L. J.; Moller, D. E. Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action. J. Clin. Invest. 2001, 108, 1167-1174.
14. Hawley, S. A.; Gadalla, A. E.; Olsen, G. S.; Hardie, D. G. The Antidiabetic Drug Metformin Activates the AMP-Activated Protein Kinase Cascade via an Adenine Nucleotide-Independent Mechanism. Diabetes 2002, 51, 2420-2425.
15. Sweeney, D.; Raymera, M. L.; Lockwood, T. D. Antidiabetic and Antimalarial Biguanide Drugs are Metal-Interactive Antiproteolytic Agents. Biochem. Pharmacol. 2003, 66, 663-677.
16. Ruggiero-Lopez, D.; Lecomte, M.; Moinet, G.; Patereau, G.; Lagarde, M.; Wiernsperger, N. Reaction of Metformin with Dicarbonyl Compounds: Possible Implication in the Inhibition of Advanced Glycation End Product Formation. Biochem. Pharmacol. 1999, 58, 1765-1773.
17. Mišur, I.; Turk, Z. Substituted Guanidine Compounds as Inhibitors of Nonenzymatic Glycation in vitro. Croat. Chem. Acta 2001, 74, 455-465.
18. Glennon, R. A.; Daoud, M. K.; Dukat, M.; Teitler, M.; Herrick-Davis, K.; Purohit, A.; Syed, H. Arylguanidine and Arylbiguanide Binding at 5-HT3 Serotonin Receptors: A QSAR Study. Bioorg. Med. Chem. 2003, 11, 4449-4454.
19. Setter, S. M.; Iltz, J. L.; Thams, J.; Campbell, R. K. Metformin Hydrochloride in the Treatment of Type 2 Diabetes Mellitus: A Clinical Review with a Focus on Dual Therapy. Clin. Therap. 2003, 12, 2991-3026.
20. Pinkerton, A.; Schwarzenbach, D. Structural Studies on Biguanide and Related Species: Correlation of Protonation Energy with Molecular Structure. J. Chem. Soc., Dalton Trans. B 1978, 34, 989-996.
21. Ray, P. Complex Compounds of Biguanides and Guanylureas with Metallic Elements. Chem. Rev. 1960, 313-359.
22. + ion: The Simplest Source for Water-Stable Manganese(IV). Chem. Commun. 2001, 323-324.
23. Anderson, K. B.; Franich, R. A.; Kroese, H. W.; Meder, R.; Rickard, C. E. F. The Structure of Biguanide Complexes of Boron. Polyhedron 1995, 14, 1149-1153.
24. Marchi, A.; Marvelli, L.; Cattabriga, M.; Rossi, R.; Neves, M.; Bertolasi, V.; Ferretti, V. Technetium(V) and Rhenium(V) Complexes of Biguanide Derivatives: Crystal Structures. J. Chem. Soc., Dalton Trans. 1999, 1937-1943.
25. 2O. Transition Met. Chem. (Dordrecht, Neth.) 1978, 3, 69-76.
26. Ernst, S. R.; Cagle, F. W., Jr. Biguanide. Acta Crystallogr., Sect. B 1977, 33, 235-237.
27. Ernst, S. R. Biguanide Hydrochloride. Acta Crystallogr., Sect. B 1977, 33, 237-240.
28. 5· 2HCl. Indian J. Phys. 1975, 49, 707-708.
29. Gadre, S. R.; Shirsat, R. N. Electrostatics of Atoms and Molecules; Universities Press: Hyderabad, India, 2000.
30. (a) Murray, J. S.; Politzer, P. The Use of Molecular Electrostatic Potential in Medicinal Chemistry. In Quantum Medicinal Chemistry. Wiley-VCH: New York, 2002; Vol. 17, pp 233-254.
31. (b) Höltje, H.-D.; Höltje, M. Applications of Quantum Chemical Methods in Drug Design. Quantum Medicinal Chemistry; Wiley-VCH: New York, 2002; Vol. 17, pp 255-274.
32. (a) Foresman, J. B.; Frisch, Æ. Exploring Chemistry with Electronic Structure Methods; Gaussian Inc.: Pittsburgh, PA, 1998.
33. (b) Hehre, W. J.; Radom, L.; Schleyer, P. V. R.; Pople, J. A. Ab Initio Molecular Orbital Theory; Wiley: New York, 1985.
34. Ochterski, J. W. Thermochemistry in Gaussian. http:// Gaussian.com/g_whitepap/thermo.htm.
35. (a) Parr, R. G.; Yang, W. Density Functional Theory of Atoms and Molecules; Oxford University Press: New York, 1989.
36. (b) Bartolotti, L. J.; Fluchick, K. In Reviews in Computational Chemistry; Lipkowitz, K. B., Boyd, D. B., Eds.; VCH Publishers: New York, 1996; Vol. 7, p 187.
37. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.; Vreven, T., Jr.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian-03 suite of programs; Gaussian, Inc.: Pittsburgh, PA, 2003.
38. (a) Becke, A. D. Density-Functional Thermochemistry. III. The Role of Exact Exchange. J. Chem. Phys. 1993, 98, 5648-5652.
39. (b) Lee, C.; Yang, W.; Parr, R. G. Development of the Colle-Salvetti Correlation-Energy Formula into a Functional of the Electron Density. Phys. Rev. B 1988, 37, 785-789.
40. (c) Perdew, J. P.; Wang, Y. Accurate and Simple Analytic Representation of the Electron-Gas Correlation Energy. Phys. Rev. B 1992, 45, 13244-13249.
41. Krishan, R.; Frisch, M. J.; Pople, J. A. Contribution of Triple Substitutions to the Electron Correlation Energy in Fourth Order Perturbation Theory. J. Chem. Phys. 1980, 72, 4244-4245.
42. Scott, A. P.; Radom, L. Harmonic Vibrational Frequencies: An Evaluation of Hartree-Fock, Møller-Plesset, Quadratic Configuration Interaction, Density Functional Theory, and Semiempirical Scale Factors. J. Phys. Chem. 1996, 100, 16502-16513.
43. Curtiss, L. A.; Raghavachari, K.; Pople, J. A. Gaussian-2 Theory Using Reduced Møller-Plesset Orders. J. Chem. Phys. 1993, 98, 1293-1298.
44. (a) Reed, A. E.; Weinstock, R. B.; Wienhold, F. Natural Population Analysis. J. Chem. Phys. 1985, 83, 735-746.
45. (b) Reed, A. E.; Wienhold, F.; Curtiss, L. A. Intermolecular Interactions from a Natural Bond Orbital, Donor-Acceptor Viewpoint. Chem. Rev. 1988, 88, 899-926.
46. (a) Krygowski, T. M. Crystallographic Studies of Inter- and Intramolecular Interactions Reflected in Aromatic Character of Π-Electron Systems. J. Chem. Inf. Comput. Sci. 1993, 33, 70-78.
47. (b) Krygowski, T. M.; Cyrañski, M. K.; Anulewicz-Ostrowska, R. Guanidinium Cation-An Acyclic Analogue of Benzene? Pol. J. Chem. 2001, 75, 1939-1942.
48. Hehre, W. J. A Guide to Molecular Mechanics and Quantum Chemical Calculations; Wavefunction: Irvine, 2001.
49. An additional tautomeric form can be theoretically envisaged as shown below. However, on the potential energy (PE) surface of biguanide, this tautomer could not be located. Complete optimization on this structure led to 10.
50. (a) Bharatam, P. V.; Iqbal, P.; Malde, A.; Tiwari, R. Electron Delocalization in Aminoguanidine: A Computational Study. J. Phys. Chem. 2004, 108, 10509-10517.
51. (b) Lammertsma, K.; Prasad, B. V. Nitro ⇌ aci-Nitro Tautomerism. J. Am. Chem. Soc. 1993, 115, 2348-2351.
52. (c) Lammertsma, K.; Prasad, B. V. Imine ⇌ Enamine Tautomerism. J. Am. Chem. Soc. 1994, 116, 642-650.
53. (d) Lammertsma, K.; Bharatam, P. V. Keto ⇌ Enol, Imine ⇌ Enamine, Nitro ⇌ aci-Nitro Tautomerism and their Interrelationship in Substituted Nitroethylenes. Keto, Imine, Nitro, and Vinyl Substituent Effects and the Importance of H-bonding. J. Org. Chem. 2000, 65, 4662-4670.
54. (a) Bharatam, P. V.; Moudgil, R.; Kaur, D. Electron Delocalization in Isocyanates, Formamides, and Ureas: Importance of Orbital Interactions. J. Phys. Chem. 2003, 107, 1627-1634.
55. (b) Bharatam, P. V.; Uppal, P.; Amita, A. G.; Kaur, D. Theoretical Investigation on the Conformational Preferences in Sulfinimines. J. Chem. Soc., Perkin Trans. 2000, 2, 43.
56. (c) Bharatam, P. V.; Amita, A. G.; Kaur, D. Electronic Structure of N-sulfenylimines. J. Phys. Org. Chem. 2003, 16, 183-189.
57. (d) Moudgil, R.; Bharatam, P. V.; Kaur, R.; Kaur, D. Theoretical Studies on Electron Delocalization in Selenourea. Proc. Ind. Acad. Sci. (Chem. Sci.) 2002, 114, 223-230.
58. Maksic, Z. B.; Kovacevic, B. Absolute Proton Affinity of Some Polyguanides. J. Org. Chem. 2000, 65, 3303-3309.
59. +))].